Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Bologna | OTHER |
| University of Milan | OTHER |
| University of Turin, Italy | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In a 3 years longitudinal, observational, multicentre study, about 500 women will be recruited and followed-up from early pregnancy (10-15 gestational week) until 12 months after delivery. The primary aim of the present study is to systematically explore and characterize risk factors for perinatal depression (PND) by prospective sleep assessment (using wrist actigraphy, polysomnography and various sleep questionnaires) and blood based analysis of potential markers during the perinatal period (Life-ON study). Secondary aims are to explore the relationship between specific genetic polymorphisms and PND (substudy Life-ON1), to investigate the effectiveness of BLT in treating PND (substudy Life-ON2) and to test whether a short term trial of BLT during pregnancy can prevent PND (substudy Life-ON3).
The characterization of specific predictive and risk factors for PND may substantially contribute to improve preventive medical and social strategies for the affected women. The study results are expected to promote a better understanding of the relationship between sleep disorders and the development of PND and to confirm, in a large sample of women, the safety and efficacy of BLT both in prevention and treatment of PND.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Bright light therapy (BLT) | Experimental | Bright light therapy (10'000 lux) for 30 minutes after wake-up using Philips EnergyUp EnergyLight HF3419/01 |
|
| Placebo dim light | Placebo Comparator | Placebo dim light (50 lux) for 30 minutes after wake-up using Philips EnergyUp EnergyLight HF3419/01 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Philips EnergyUp EnergyLight HF3419/01 | Device | Bright light therapy (10'000 lux) for 60 minutes after wake-up |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Depression Score as assessed by the Edinburgh Postnatal Depression Scale (EPDS) | during 6 weeks of light treatment plus 12 months observation | |
| Change in Depression Score as assessed by the Hamilton Depression Rating scale - 21 items (HDRS-21) | during 6 weeks of light treatment plus 12 months observation | |
| Change in Depression Score as assessed by the Montgomery-Asberg Depression Rating Scale (MADRS) | during 6 weeks of light treatment plus 12 months observation |
| Measure | Description | Time Frame |
|---|---|---|
| Objective sleep-related markers and risk factors for perinatal depression as assessed by home polysomnography | at 23th-25th week of gestation | |
| Objective sleep-related markers and risk factors for perinatal depression as assessed by wrist actigraphy | observation over a period of 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Neurocenter of Southern Switzerland | Lugano | Canton Ticino | 6900 | Switzerland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35876837 | Derived | Garbazza C, Cirignotta F, D'Agostino A, Cicolin A, Hackethal S, Wirz-Justice A, Cajochen C, Manconi M; "Life-ON" study group. Sustained remission from perinatal depression after bright light therapy: A pilot randomised, placebo-controlled trial. Acta Psychiatr Scand. 2022 Oct;146(4):350-356. doi: 10.1111/acps.13482. Epub 2022 Aug 3. | |
| 27814712 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Philips EnergyUp EnergyLight HF3419/01 | Device | Placebo dim light (500 lux) for 60 minutes after wake-up |
|
| Analysis of genetic risk factors for perinatal depression by single blood test | at 23th-25th week of gestation |
| Subjective mood changes as assessed by the Visual Analog Scale for Depression (VAS) | during 6 weeks of light treatment plus 12 months observation |
| Number of participants with treatment-related adverse events as assessed by the Systematic Assessment for Treatment Emergent Events (SAFTEE) | during 6 weeks of light treatment plus 12 months observation |
| Baiardi S, Cirignotta F, Cicolin A, Garbazza C, D'Agostino A, Gambini O, Giordano A, Canevini M, Zambrelli E, Marconi AM, Mondini S, Borgwardt S, Cajochen C, Rizzo N, Manconi M. Chronobiology, sleep-related risk factors and light therapy in perinatal depression: the "Life-ON" project. BMC Psychiatry. 2016 Nov 4;16(1):374. doi: 10.1186/s12888-016-1086-0. |
| ID | Term |
|---|---|
| D003863 | Depression |
| D019052 | Depression, Postpartum |
| D003866 | Depressive Disorder |
| D003865 | Depressive Disorder, Major |
| D019964 | Mood Disorders |
| D011248 | Pregnancy Complications |
| D011644 | Puerperal Disorders |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D001523 | Mental Disorders |
Not provided
Not provided